26th Jul 2009 Vision RT continues to advance further its revolutionary solution for markerless patient setup, surveillance and respiratory gating during radiation therapy. These developments are supported by the addition of several new customers in the USA in recent months. New AlignRT®, GateCT® and GateRT® systems have been purchased by: the University of Maryland, MD; York Cancer Center, PA; Moffitt Cancer Center, FL; MD Anderson Cancer Center, TX; University California San Francisco (UCSF), CA; Dana Farber Cancer Institute, MA; Rocky Mountain Cancer Centers, CO; University of North Carolina (UNC), NC; UF & Shands Jacksonville, FL; Memorial Sloan Kettering Cancer Center, NY; Emory University, GA; Massachusetts General Hospital, MA. Tim Fox Ph.D., Director of Medical Physics at Emory comments: “We are very excited about using AlignRT® for real time patient tracking during radiation delivery. In particular, with the increasing tendency towards higher dose and fewer fractions, the need for monitoring motion continuously throughout treatment becomes paramount”. “Vision RT’s acceptance by the majority of leading institutions in the USA is testament to the significance of real time patient tracking in radiation therapy” comments Tim Nicholson, Vision RT’s Director of Sales in North America. “This is being reaffirmed by new and repeat purchases from top academic centers as well as by sales to community hospitals and to free standing clinics.”
Background
Vision RT Limited has developed a novel approach to enhance the crucial process of patient setup and surveillance during radiation therapy for the treatment of cancer. Vision RT’s revolutionary products, AlignRT®, GateCT® and GateRT® utilize a proprietary real-time 3D surface imaging technology to provide exceptional speed and accuracy designed to improve the efficacy and precision of radiation treatments. Further information on Vision RT and its products may be found on www.visionrt.com.
|
